Ben Stocks

Ben Stocks is the group chief executive at Porvair Plc. Prior to this, they were the CEO at Leckey from July 2018 to June 2022. Ben was promoted to CEO in October 2019 and facilitated the owner-founder's move to non-executive chairman. In August 2020, they negotiated the sale of the company to PE-backed Sunrise Medical. Post-sale, they were promoted to the executive board of Sunrise Medical and was responsible for the integration of Leckey and the ongoing leadership of the group's enlarged paediatric rehab portfolio.

From April 2017 to January 2018, Stocks served as the group strategy director at WiggleCRC. During this time, they were promoted to the group executive board responsible for strategy, planning and business development across both CRC and Wiggle brands. Ben also worked with the group's PE sponsor, Bridgepoint, on the acquisition of €100m German rival, Bike24 GmbH. Additionally, they were responsible for leading commercial and synergy assessment, coordinating due diligence work streams, and establishing intra group trading and management arrangements.

Ben Stocks completed an MBA at the University of Bath with a grade average of 72%. Ben then became a Fellow of the Chartered Association of Certified Accountants (FCA) through the ICAEW. Next, they completed a BSc (Hons) in Economics at the University of York. Finally, they spent an exchange year studying Economics at UC San Diego.

A direct report to Ben Stocks is and Chris Tyler - Group Finance Director.